These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23305696)

  • 1. ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics.
    Larson BA; Bii M; Henly-Thomas S; McCoy K; Sawe F; Shaffer D; Rosen S
    J Int AIDS Soc; 2013 Jan; 16(1):18026. PubMed ID: 23305696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study.
    Scott CA; Iyer HS; McCoy K; Moyo C; Long L; Larson BA; Rosen S
    BMC Public Health; 2014 Mar; 14():296. PubMed ID: 24684772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya.
    Larson BA; Bii M; Halim N; Rohr JK; Sugut W; Sawe F
    PLoS One; 2018; 13(8):e0200199. PubMed ID: 30096177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis.
    Scott CA; Iyer H; Bwalya DL; McCoy K; Meyer-Rath G; Moyo C; Bolton-Moore C; Larson B; Rosen S
    PLoS One; 2013; 8(6):e67910. PubMed ID: 23840788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients.
    Nichols BE; Cele R; Lekodeba N; Tukei B; Ngorima-Mabhena N; Tiam A; Maotoe T; Sejana MV; Faturiyele IO; Chasela C; Rosen S; Fatti G
    J Int AIDS Soc; 2021 Apr; 24(4):e25692. PubMed ID: 33838012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR'].
    Kuhlmann A; Mittendorf T; Hower M; Heiken H; Gerschmann S; Klauke S; Lutz T; Bogner J; Degen O; van Lunzen J; Bachmann C; Stellbrink HJ; Schmidt W; Leistner I; Mahlich J; Ranneberg B; Stoll M
    Gesundheitswesen; 2015 Jun; 77(6):e133-42. PubMed ID: 25247761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the cost of providing outpatient HIV counseling and testing and antiretroviral therapy services in selected public health facilities in Nigeria?
    Aliyu HB; Chuku NN; Kola-Jebutu A; Abubakar Z; Torpey K; Chabikuli ON
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):221-5. PubMed ID: 22820805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining catastrophic costs and benefit incidence of subsidized antiretroviral treatment (ART) programme in south-east Nigeria.
    Onwujekwe O; Dike N; Chukwuka C; Uzochukwu B; Onyedum C; Onoka C; Ichoku H
    Health Policy; 2009 May; 90(2-3):223-9. PubMed ID: 19036466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast-track treatment initiation counselling in South Africa: A cost-outcomes analysis.
    Larson BA; Pascoe SJS; Huber A; Long LC; Murphy J; Miot J; Fraser-Hurt N; Fox MP; Rosen S
    PLoS One; 2021; 16(3):e0248551. PubMed ID: 33735206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH Studys.
    Shade SB; Osmand T; Luo A; Aine R; Assurah E; Mwebaza B; Mwai D; Owaraganise A; Mwangwa F; Ayieko J; Black D; Brown LB; Clark TD; Kwarisiima D; Thirumurthy H; Cohen CR; Bukusi EA; Charlebois ED; Balzer L; Kamya MR; Petersen ML; Havlir DV; Jain V
    AIDS; 2018 Sep; 32(15):2179-2188. PubMed ID: 30134294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost and outcomes of paediatric antiretroviral treatment in South Africa.
    Meyer-Rath G; Brennan A; Long L; Ndibongo B; Technau K; Moultrie H; Fairlie L; Coovadia A; Rosen S
    AIDS; 2013 Jan; 27(2):243-50. PubMed ID: 23014517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.
    Kimaro GD; Mfinanga S; Simms V; Kivuyo S; Bottomley C; Hawkins N; Harrison TS; Jaffar S; Guinness L;
    PLoS One; 2017; 12(2):e0171917. PubMed ID: 28234969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti.
    Koenig SP; Bang H; Severe P; Jean Juste MA; Ambroise A; Edwards A; Hippolyte J; Fitzgerald DW; McGreevy J; Riviere C; Marcelin S; Secours R; Johnson WD; Pape JW; Schackman BR
    PLoS Med; 2011 Sep; 8(9):e1001095. PubMed ID: 21949643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provision of bednets and water filters to delay HIV-1 progression: cost-effectiveness analysis of a Kenyan multisite study.
    Kern E; Verguet S; Yuhas K; Odhiambo FH; Kahn JG; Walson J
    Trop Med Int Health; 2013 Aug; 18(8):916-24. PubMed ID: 23659539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of intermittent versus continuous antiretroviral therapy in patients with controlled HIV infection: a substudy of the ANRS 106 Window Trial.
    Charreau I; Jeanblanc G; Tangre P; Boyer L; Saouzanet M; Marchou B; Molina JM; Aboulker JP; Durand-Zaleski I;
    J Acquir Immune Defic Syndr; 2008 Dec; 49(4):416-21. PubMed ID: 18931625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa.
    Long LC; Rosen SB; Brennan A; Moyo F; Sauls C; Evans D; Modi SL; Sanne I; Fox MP
    PLoS One; 2016; 11(12):e0168118. PubMed ID: 27942005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between prescription cost sharing and adherence to initial combination antiretroviral therapy in commercially insured antiretroviral-naïve patients with HIV.
    Johnston SS; Juday T; Seekins D; Espindle D; Chu BC
    J Manag Care Pharm; 2012 Mar; 18(2):129-45. PubMed ID: 22380472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
    Cunnama L; Abrams EJ; Myer L; Gachuhi A; Dlamini N; Hlophe T; Kikuvi J; Langwenya N; Mthethwa S; Mudonhi D; Nhlabatsi B; Nuwagaba-Biribonwoha H; Okello V; Sahabo R; Zerbe A; Sinanovic E
    Trop Med Int Health; 2018 Sep; 23(9):950-959. PubMed ID: 29956426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.